Asia Pacific GMP Cell Therapy Consumables Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem
Description
Asia Pacific GMP Cell Therapy Consumables Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
The Asia Pacific GMP cell therapy consumables market is expected to grow from US$ 1,918.28 million in 2022 to US$ 9,093.86 million by 2028; it is estimated to grow at a CAGR of 29.6% from 2022 to 2028.
Increase in Strategic Collaborations Boosts Asia Pacific GMP Cell Therapy Consumables Market
The companies in the Asia Pacific GMP cell therapy consumables market is making strategic collaborations for the development of new products and cell therapy treatments. A few strategic collaborations in the GMP cell therapy consumables market are mentioned below:
In October 2022, Pluristyx, panCELLa, and Implant Therapeutics management announced the corporate merger, pending shareholder approval. The merged company will combine complementary portfolios to offer end-to-end customer support and provide increased access to a wide range of induced pluripotent stem cell (iPSC)-related products and services. The integrated technology and service offerings will accelerate the development and delivery of revolutionary cell therapies to patients. In June 2022, CellPoint and AboundBio entered into definitive agreements with Galapagos, propelling Galapagos into next-generation cell therapy while significantly broadening its portfolio and capabilities. The aim of this agreement is to expand the current market for CAR-T therapies and have an important impact on patients needing additional and improved treatment options. In November 2021, Laurus Labs signed an investment agreement with Immunoadoptive Cell Therapy Private Limited (ImmunoACT), an advanced cell and gene therapy company, to acquire a 26.62% stake (fully diluted basis) for US$ 4.66, subject to the fulfillment of certain conditions. Thus, the growing number of strategic collaborations among market players for the development of cell therapy has propelled the use of GMP cell therapy consumables to achieve the desired products, which drives the growth of the Asia Pacific GMP cell therapy consumables market.
Asia Pacific GMP cell therapy consumables Market Overview
The Asia Pacific GMP cell therapy consumables market is segmented into China, Japan, India, South Korea, Australia, South Korea, and the Rest of Asia Pacific. The Asia Pacific GMP cell therapy consumables market growth is attributed to the growing pharmaceutical industry, a rising number of players in the region, an increasing number of regulations, and a rising awareness about cell therapy. China was the first country worldwide to approve gene therapy in 2003. However, developments in cell and gene therapy (CGT) were delayed due to a lack of clear and strict regulatory frameworks. The rapid advancements of CGTs' development worldwide and their therapeutic potential have triggered the government to conduct regulatory reforms to promote the normative development of CGTs in China. In 2017, the regulations regarding cell therapy were changed in such a manner that products of all cell therapy categories boomed. According to research conducted by Nature, approximately 953 cell and gene therapy clinical trials were initiated till March 2021, including Investigational New Drugs (IND), registered trials, and investigator-initiated trials (IITs). Encouraged by policy support, the remarkable progress for CGTs in China has been observed over the past few years, thereby making China a leading country in the development of CGTs.
Asia Pacific GMP Cell Therapy Consumables Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific GMP Cell Therapy Consumables Market Segmentation
The Asia Pacific GMP cell therapy consumables market is segmented on the basis of product, cell therapy, process, end use, and country.
Based on product, the GMP cell therapy consumables market is segmented into kits, reagents/molecular biology reagents, growth factors/cytokines and interleukins (including protein and nucleic acid purification buffers), and others. The kits segment held the largest share of the market in 2022. Based on cell therapy, the GMP cell therapy consumables market is segmented into NK cell therapy, stem cell therapy, T-cell therapy, and others. The T-cell therapy segment registered the largest share of the market in 2022. Based on process, the Asia Pacific GMP cell therapy consumables market is segmented into cell collection and characterization/sorting and separation, cell culture and expansion/preparation, cryopreservation, cell processing and formulation, cell isolation and activation, cell distribution/handling, process monitoring and control/readministration/quality assurance, and others. The cell collection and characterization/sorting and separation segment held the largest share of the market in 2022. Based on end use, the Asia Pacific GMP cell therapy consumables market is segmented into clinical, commercial, and research. The clinical segment held the largest share of the market in 2022. Based on country, the Asia Pacific GMP cell therapy consumables market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the market in 2022. Bio-Techne Corp, BPS Bioscience Inc, Corning Inc, FUJIFILM Irvine Scientific Inc, Global Life Sciences Solutions USA LLC, Lonza Group AG, Merck KGaA, Miltenyi Biotec BV & Co KG, Sartorius AG, and Thermo Fisher Scientific Inc are the leading companies operating in the Asia Pacific GMP cell therapy consumables market.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific GMP cell therapy consumables market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific GMP cell therapy consumables market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the GMP cell therapy consumables market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
The Asia Pacific GMP cell therapy consumables market is expected to grow from US$ 1,918.28 million in 2022 to US$ 9,093.86 million by 2028; it is estimated to grow at a CAGR of 29.6% from 2022 to 2028.
Increase in Strategic Collaborations Boosts Asia Pacific GMP Cell Therapy Consumables Market
The companies in the Asia Pacific GMP cell therapy consumables market is making strategic collaborations for the development of new products and cell therapy treatments. A few strategic collaborations in the GMP cell therapy consumables market are mentioned below:
In October 2022, Pluristyx, panCELLa, and Implant Therapeutics management announced the corporate merger, pending shareholder approval. The merged company will combine complementary portfolios to offer end-to-end customer support and provide increased access to a wide range of induced pluripotent stem cell (iPSC)-related products and services. The integrated technology and service offerings will accelerate the development and delivery of revolutionary cell therapies to patients. In June 2022, CellPoint and AboundBio entered into definitive agreements with Galapagos, propelling Galapagos into next-generation cell therapy while significantly broadening its portfolio and capabilities. The aim of this agreement is to expand the current market for CAR-T therapies and have an important impact on patients needing additional and improved treatment options. In November 2021, Laurus Labs signed an investment agreement with Immunoadoptive Cell Therapy Private Limited (ImmunoACT), an advanced cell and gene therapy company, to acquire a 26.62% stake (fully diluted basis) for US$ 4.66, subject to the fulfillment of certain conditions. Thus, the growing number of strategic collaborations among market players for the development of cell therapy has propelled the use of GMP cell therapy consumables to achieve the desired products, which drives the growth of the Asia Pacific GMP cell therapy consumables market.
Asia Pacific GMP cell therapy consumables Market Overview
The Asia Pacific GMP cell therapy consumables market is segmented into China, Japan, India, South Korea, Australia, South Korea, and the Rest of Asia Pacific. The Asia Pacific GMP cell therapy consumables market growth is attributed to the growing pharmaceutical industry, a rising number of players in the region, an increasing number of regulations, and a rising awareness about cell therapy. China was the first country worldwide to approve gene therapy in 2003. However, developments in cell and gene therapy (CGT) were delayed due to a lack of clear and strict regulatory frameworks. The rapid advancements of CGTs' development worldwide and their therapeutic potential have triggered the government to conduct regulatory reforms to promote the normative development of CGTs in China. In 2017, the regulations regarding cell therapy were changed in such a manner that products of all cell therapy categories boomed. According to research conducted by Nature, approximately 953 cell and gene therapy clinical trials were initiated till March 2021, including Investigational New Drugs (IND), registered trials, and investigator-initiated trials (IITs). Encouraged by policy support, the remarkable progress for CGTs in China has been observed over the past few years, thereby making China a leading country in the development of CGTs.
Asia Pacific GMP Cell Therapy Consumables Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific GMP Cell Therapy Consumables Market Segmentation
The Asia Pacific GMP cell therapy consumables market is segmented on the basis of product, cell therapy, process, end use, and country.
Based on product, the GMP cell therapy consumables market is segmented into kits, reagents/molecular biology reagents, growth factors/cytokines and interleukins (including protein and nucleic acid purification buffers), and others. The kits segment held the largest share of the market in 2022. Based on cell therapy, the GMP cell therapy consumables market is segmented into NK cell therapy, stem cell therapy, T-cell therapy, and others. The T-cell therapy segment registered the largest share of the market in 2022. Based on process, the Asia Pacific GMP cell therapy consumables market is segmented into cell collection and characterization/sorting and separation, cell culture and expansion/preparation, cryopreservation, cell processing and formulation, cell isolation and activation, cell distribution/handling, process monitoring and control/readministration/quality assurance, and others. The cell collection and characterization/sorting and separation segment held the largest share of the market in 2022. Based on end use, the Asia Pacific GMP cell therapy consumables market is segmented into clinical, commercial, and research. The clinical segment held the largest share of the market in 2022. Based on country, the Asia Pacific GMP cell therapy consumables market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the market in 2022. Bio-Techne Corp, BPS Bioscience Inc, Corning Inc, FUJIFILM Irvine Scientific Inc, Global Life Sciences Solutions USA LLC, Lonza Group AG, Merck KGaA, Miltenyi Biotec BV & Co KG, Sartorius AG, and Thermo Fisher Scientific Inc are the leading companies operating in the Asia Pacific GMP cell therapy consumables market.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific GMP cell therapy consumables market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific GMP cell therapy consumables market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the GMP cell therapy consumables market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Table of Contents
168 Pages
- 1. Introduction
- 1.1 Study Scope
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 APAC GMP Cell Therapy Consumables Market – by Product
- 1.3.2 APAC GMP Cell Therapy Consumables Market – by Cell Therapy
- 1.3.3 APAC GMP Cell Therapy Consumables Market – by End Use
- 1.3.4 APAC GMP Cell Therapy Consumables Market – by End Use
- 1.3.5 APAC GMP Cell Therapy Consumables Market – by Country
- 2. APAC GMP Cell Therapy Consumables Market – Key Takeaways
- 3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
- 4. APAC GMP Cell Therapy Consumables Market – Market Landscape
- 4.1 Overview
- 4.2 APAC PEST Analysis
- 4.3 Experts’ Opinion
- 5. APAC GMP Cell Therapy Consumables Market – Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Rise in Research & Development and Drug Discovery
- 5.1.2 Increase in Strategic Collaborations
- 5.2 Market Restraints
- 5.2.1 Stringent Regulatory Policies
- 5.3 Future Trends
- 5.3.1 Increasing Clinical Trials and Rising GMP Demand
- 5.4 Impact Analysis
- 6. GMP Cell Therapy Consumables Market – APAC Analysis
- 6.1 APAC GMP Cell Therapy Consumables Market Revenue Forecast and Analysis
- 7. APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – by Product
- 7.1 Overview
- 7.2 APAC GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%)
- 7.3 Kits
- 7.3.1 Overview
- 7.3.2 Kits: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 7.4 Reagents/ Molecular Biology Reagents
- 7.4.1 Overview
- 7.4.2 Reagents/ Molecular Biology Reagents: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 7.5 Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers)
- 7.5.1 Overview
- 7.5.2 Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 8. APAC GMP Cell Therapy Consumables Market Analysis and Forecasts to 2028 – by Cell Therapy
- 8.1 Overview
- 8.2 APAC GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%)
- 8.3 NK Cell Therapy
- 8.3.1 Overview
- 8.3.2 NK Cell Therapy: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 8.4 Stem Cell Therapy
- 8.4.1 Overview
- 8.4.2 Stem Cell Therapy: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 8.5 T-cell Therapy
- 8.5.1 Overview
- 8.5.2 T-cell Therapy: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 9. APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – by End Use
- 9.1 Overview
- 9.2 APAC GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
- 9.3 Clinical
- 9.3.1 Overview
- 9.3.2 Clinical: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 9.4 Commercial
- 9.4.1 Overview
- 9.4.2 Commercial: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 9.5 Research
- 9.5.1 Overview
- 9.5.2 Research: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10. APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – by Process
- 10.1 Overview
- 10.2 APAC GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
- 10.3 Cell Collection and Characterization/Sorting and Separation
- 10.3.1 Overview
- 10.3.2 Cell Collection and Characterization/ Sorting and Separation: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.4 Cell Culture and Expansion/Preparation
- 10.4.1 Overview
- 10.4.2 Cell Culture and Expansion/Preparation: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.5 Cryopreservation
- 10.5.1 Overview
- 10.5.2 Cryopreservation: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.6 Cell Processing and Formulation
- 10.6.1 Overview
- 10.6.2 Cell Processing and Formulation: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.7 Cell Isolation and Activation
- 10.7.1 Overview
- 10.7.2 Cell Isolation and Activation: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.8 Cell Distribution/Handling
- 10.8.1 Overview
- 10.8.2 Cell Distribution/Handling: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.9 Process Monitoring and Control/Readministration/Quality Assurance
- 10.9.1 Overview
- 10.9.2 Process Monitoring and Control/Readministration/Quality Assurance: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.10 Other
- 10.10.1 Overview
- 10.10.2 Other: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11. APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – Country Analysis
- 11.1 Overview
- 11.1.1 APAC: GMP Cell Therapy Consumables Market, by Country, 2021 & 2028 (%)
- 11.1.1.1 China: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.1.1 Overview
- 11.1.1.1.2 China: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.1.3 China: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ Million)
- 11.1.1.1.4 China: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ Million)
- 11.1.1.1.5 China GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ Million)
- 11.1.1.1.6 China GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ Million)
- 11.1.1.2 Japan: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.2.1 Overview
- 11.1.1.2.2 Japan: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.2.3 Japan: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ Million)
- 11.1.1.2.4 Japan: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ Million)
- 11.1.1.2.5 Japan: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ Million)
- 11.1.1.2.6 Japan: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ Million)
- 11.1.1.3 India: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.3.1 Overview
- 11.1.1.3.2 India: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.3.3 India: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ Million)
- 11.1.1.3.4 India: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ Million)
- 11.1.1.3.5 India: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ Million)
- 11.1.1.3.6 India: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ Million)
- 11.1.1.4 South Korea: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.4.1 Overview
- 11.1.1.4.2 South Korea: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.4.3 South Korea: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ Million)
- 11.1.1.4.4 South Korea: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ Million)
- 11.1.1.4.5 South Korea: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ Million)
- 11.1.1.4.6 South Korea: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ Million)
- 11.1.1.5 Australia: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.5.1 Overview
- 11.1.1.5.2 Australia: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.5.3 Australia: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ Million)
- 11.1.1.5.4 Australia: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ Million)
- 11.1.1.5.5 Australia: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ Million)
- 11.1.1.5.6 Australia: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ Million)
- 11.1.1.6 Rest of APAC: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.6.1 Overview
- 11.1.1.6.2 Rest of APAC: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.6.3 Rest of APAC: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ Million)
- 11.1.1.6.4 Rest of APAC: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ Million)
- 11.1.1.6.5 Rest of APAC: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ Million)
- 11.1.1.6.6 Rest of APAC: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ Million)
- 12. GMP Cell Therapy Consumables Market – Industry Landscape
- 12.1 Overview
- 12.2 Growth Strategies in GMP Cell Therapy Consumables Market
- 12.3 Inorganic Growth Strategies
- 12.3.1 Overview
- 12.4 Organic Growth Strategies
- 12.4.1 Overview
- 13. Company Profiles
- 13.1 Sartorius AG
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 Thermo Fisher Scientific Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 Miltenyi Biotec BV & Co KG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 Bio-Techne Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 Corning Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 FUJIFILM Irvine Scientific Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 Lonza Group AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 BPS Bioscience Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 Merck KGaA
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 13.10 Global Life Sciences Solutions USA LLC
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
- 14. Appendix
- 14.1 About The Insight Partners
- 14.2 Glossary of Terms
- LIST OF TABLES
- Table 1. China GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ Million)
- Table 2. China GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
- Table 3. China GMP Cell Therapy Consumables Market, by End Use – Revenue and Forecast to 2028 (US$ Million)
- Table 4. China GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ Million)
- Table 5. Japan GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ Million)
- Table 6. Japan GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
- Table 7. Japan GMP Cell Therapy Consumables Market, by End Use – Revenue and Forecast to 2028 (US$ Million)
- Table 8. Japan GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ Million)
- Table 9. India GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ Million)
- Table 10. India GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
- Table 11. India GMP Cell Therapy Consumables Market, by End Use – Revenue and Forecast to 2028 (US$ Million)
- Table 12. India GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ Million)
- Table 13. South Korea GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ Million)
- Table 14. South Korea GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
- Table 15. South Korea GMP Cell Therapy Consumables Market, by End Use – Revenue and Forecast to 2028 (US$ Million)
- Table 16. South Korea GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ Million)
- Table 17. Australia GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ Million)
- Table 18. Australia GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
- Table 19. Australia GMP Cell Therapy Consumables Market, by End Use – Revenue and Forecast to 2028 (US$ Million)
- Table 20. Australia GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ Million)
- Table 21. Rest of APAC GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ Million)
- Table 22. Rest of APAC GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
- Table 23. Rest of APAC GMP Cell Therapy Consumables Market, by End Use – Revenue and Forecast to 2028 (US$ Million)
- Table 24. Rest of APAC GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ Million)
- Table 25. Recent Inorganic Growth Strategies in the GMP Cell Therapy Consumables Market
- Table 26. Recent Organic Growth Strategies in GMP Cell Therapy Consumables Market
- Table 27. Glossary of Terms
- LIST OF FIGURES
- Figure 1. APAC GMP Cell Therapy Consumables Market Segmentation
- Figure 2. APAC GMP Cell Therapy Consumables Market, by Country
- Figure 3. APAC GMP Cell Therapy Consumables Market Overview
- Figure 4. Kits Segment Held the Largest Share of Product Segment in APAC GMP Cell Therapy Consumables Market
- Figure 5. India Expected to Show Remarkable Growth During Forecast Period
- Figure 6. APAC: PEST Analysis
- Figure 7. Experts’ Opinion
- Figure 8. APAC GMP Cell Therapy Consumables Market: Impact Analysis of Drivers and Restraints
- Figure 9. APAC GMP Cell Therapy Consumables Market – Revenue Forecast and Analysis – 2019–2028
- Figure 10. APAC GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%)
- Figure 11. Kits: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 12. Reagents/ Molecular Biology Reagents: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 13. Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 14. Others: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 15. APAC GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%)
- Figure 16. NK Cell Therapy: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 17. Stem Cell Therapy: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 18. T-cell Therapy: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 19. Other Applications: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 20. APAC GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
- Figure 21. Clinical: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 22. Commercial: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 23. Research: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 24. APAC GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
- Figure 25. Cell Collection and Characterization/Sorting and Separation: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 26. Cell Culture and Expansion/Preparation: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 27. Cryopreservation: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 28. Cell Processing and Formulation: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 29. Cell Isolation and Activation: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 30. Cell Distribution/Handling: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 31. Process Monitoring and Control/Readministration/Quality Assurance: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 32. Other: APAC GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 33. APAC: GMP Cell Therapy Consumables Market, by Key Country – Revenue (2021) (US$ Million)
- Figure 34. China: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 35. Japan: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 36. India: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 37. South Korea: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 38. Australia: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 39. Rest of APAC: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 40. Growth Strategies in GMP Cell Therapy Consumables Market
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
